Table 2.
Molecular subtype | Genetic features | Epigenetic features | Other characteristics |
---|---|---|---|
iCluster 1 36% |
Few CTNNB1 mutations Low expression of TERT Overexpression of proliferation markers |
microRNA signature mir-122 silencing High expression of miR-181A |
Young age Asian patients Female patients Normal Weight High grade Poor prognosis |
iCluster 2 30% |
High expression of TERT High expression of CTNNB1 HNF1A mutations |
CDKN2A silencing |
Low grade Low microvascular invasion |
iCluster 3 34% |
Chromosomal instability 17p loss TP53 mutations High activation of CTNNB1 High expression of TERT Activation of VEGF-A pathway PTEN inactivation |
CDKN2A silencing CPG Island hypomethylation |
– |
Frequencies of most prevalent alterations in the whole cohort |
TERT mutations 44% TP53 mutations 31% CTNNB1 mutations 27% CDKN2A deletion 13% APOB mutations 10% AXIN1 mutations 8% ARID1A mutations 7% |
CDKN2A silencing 54% | – |